Literature DB >> 16619130

Lactate production upon short-term non-ischemic forearm exercise in mitochondrial disorders and other myopathies.

Frank Hanisch1, Katharina Eger, Silke Bork, Holger Lehnich, Marcus Deschauer, Stephan Zierz.   

Abstract

BACKGROUND: The nonischemic forearm exercise test (NIFET) has been shown to be as effective as the classic ischemic forearm exercise test (IFET) in the diagnosis of patients with McArdle disease. Recently, the lactate increase normalized to the mechanical energy production in NIFET was suggested to have a intermediate sensitivity and satisfactory specifity for the screening of mitochondrial disorders.
METHODS: NIFET at 80% maximal contraction force (MCF) was performed in normal controls (n = 41), patients with mitochondrial disorders (n = 15) and other myopathies (diseased controls, n = 20). 26 healthy volunteers also underwent IFET at 80% MCF. The ratio of lactate increase and workload was defined as specific lactate production (mmol x s/N x l).
RESULTS: In normal controls there was no significant different lactate increase during NIFET and IFET. The workload performed showed only a weak significant positive correlation with the lactate increase in the NIFET in normal controls (r(2) = 0.20) but not in IFET and NIFET with patients. A moderate negative correlation of specific lactate production and the absolute workload was found in all groups and in both protocols (r(2) = 0.22-0.34). The specific lactate production was highest in patients with other myopathies, intermediate in patients with mitochondrial disorders and lowest in normal controls. NIFET showed a sensitivity of only 20 % and a specifity of 95% for normal controls, but only 75 % for diseased controls.
CONCLUSION: The specific lactate production during NIFET is neither sufficiently specific nor sensitive for the diagnosis of mitochondrial disorders. Increased specific lactate production during rest-to-work transition period might be caused by increased acetyl group deficits.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16619130     DOI: 10.1007/s00415-006-0101-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  21 in total

1.  Myopathy due to a defect in muscle glycogen breakdown.

Authors:  B McARDLE
Journal:  Clin Sci       Date:  1951-02       Impact factor: 6.124

Review 2.  Skeletal muscle metabolism during exercise in humans.

Authors:  M Hargreaves
Journal:  Clin Exp Pharmacol Physiol       Date:  2000-03       Impact factor: 2.557

3.  [Lactate and pyruvate blood levels in the diagnosis of mitochondrial myopathies].

Authors:  S Zierz; S Meessen; F Jerusalem
Journal:  Nervenarzt       Date:  1989-09       Impact factor: 1.214

4.  Behaviour of human motor units in different muscles during linearly varying contractions.

Authors:  C J De Luca; R S LeFever; M P McCue; A P Xenakis
Journal:  J Physiol       Date:  1982-08       Impact factor: 5.182

5.  A non-ischemic forearm exercise test for the screening of patients with exercise intolerance.

Authors:  J Y Hogrel; P Laforêt; R Ben Yaou; M Chevrot; B Eymard; A Lombès
Journal:  Neurology       Date:  2001-06-26       Impact factor: 9.910

6.  Anaerobic energy production and O2 deficit-debt relationship during exhaustive exercise in humans.

Authors:  J Bangsbo; P D Gollnick; T E Graham; C Juel; B Kiens; M Mizuno; B Saltin
Journal:  J Physiol       Date:  1990-03       Impact factor: 5.182

7.  The ischemic exercise test in normal adults and in patients with weakness and cramps.

Authors:  R A Coleman; J M Stajich; V W Pact; M A Pericak-Vance
Journal:  Muscle Nerve       Date:  1986 Mar-Apr       Impact factor: 3.217

8.  Increased acetyl group availability enhances contractile function of canine skeletal muscle during ischemia.

Authors:  J A Timmons; S M Poucher; D Constantin-Teodosiu; V Worrall; I A Macdonald; P L Greenhaff
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

9.  A nonischemic forearm exercise test for McArdle disease.

Authors:  Pedram Kazemi-Esfarjani; Elwira Skomorowska; Tina Dysgaard Jensen; Ronald G Haller; John Vissing
Journal:  Ann Neurol       Date:  2002-08       Impact factor: 10.422

10.  Only transient increase of serum CoQ subset 10 during long-term CoQ10 therapy in mitochondrial ophthalmoplegia.

Authors:  Frank Hanisch; S Zierz
Journal:  Eur J Med Res       Date:  2003-11-12       Impact factor: 2.175

View more
  1 in total

Review 1.  Inborn errors of energy metabolism associated with myopathies.

Authors:  Anibh M Das; Ulrike Steuerwald; Sabine Illsinger
Journal:  J Biomed Biotechnol       Date:  2010-05-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.